Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: Relation to invasion

Clinical and Experimental Metastasis

Volumn 19, Issue 8, 2002, Pages 709-716

  Sartor, Luigi ^a   Negro, Alessandro ^a   Barletta, Emanuela ^b   Mugnai, Gabriele ^b   Garbisa, Spiridione ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

BDNF; CNTF; Gelatinases; MT1 MMP; Neuroblastoma; uPA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INVASION; CLONE; CONTROLLED STUDY; DOSE RESPONSE; MOUSE; NERVE FIBER GROWTH; NEUROBLASTOMA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION;

ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CILIARY NEUROTROPHIC FACTOR; CLONE CELLS; DNA PRIMERS; ENDOPEPTIDASES; MATRIX METALLOPROTEINASES; MICE; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036935232     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021302802297     Document Type: Article

References (41)

1. Parrow V, Nanberg E, Heikkila J et al. Protein kinase C remains functionally active during TPA-induced neuronal differentiation of SH-SY5Y human neuroblastoma cells. J Cell Physiol 1992; 152: 536-44.
2. Pennypacker KR, Kuhn DM, Billingsley ML. Changes in the expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation. Brain Res Mol Brain Res 1989; 5: 251-8.
3. Bunone G, Borrello MG, Picetti R et al. Induction of RET protooncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp Cell Res 1995; 217: 92-9.
4. Chambaut-Guérin A-M, Martinez M-C, Hamimi C et al. Tumor necrosis factor in neuroblastoma SKNBE cells and their regulation by retinoic acid. J Neurochem 1995; 65: 537-44.
5. Menter DG, Herrmann JL, Marchetti D et al. Involvement of neurotrophins and growth factor in brain metastasis formation. Invasion Metastasis 1995; 14: 372-84.
6. Snider WD. Functions of the neurotrophins during nervous-system development - what the knockouts are teaching us. Cell 1994; 77: 627-38.
7. Lawrence G, Rylett RJ, Richardson PM et al. Differentiation effects of ciliary neurotrophic factor on human neuroblastoma cells. J Neurochem 1995; 64: 1483-90.
8. Rossino P, Volpe G, Negro A, et al. Ciliary neurotrhophic factor-induced gene expression in human neuroblastoma cell lines. Neurochem Res 1995; 20: 675-80.
9. Barletta E, Mugnai G, Ruggieri S. Inverse relationship between invasiveness and differentiative capacity in different human neuroblastoma cell lines. Int J Cancer 1997; 70: 556-60.
10. Garbisa S, Biggin S, Cavallarin N et al. Tumor invasion: Molecular shears blunted by green tea. Nat Med 1999; 4 (11): 1216.
11. Ara T, Fukuzawa M, Kusafuka T et al. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: Association with tumor progression and clinical outcome. J Pediat Surg 1998; 33: 1272-8.
12. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
13. Sato H, Takino T. Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-5.
14. Caenazzo C, Onisto M, Sartor L et al. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP): MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis. Clin Cancer Res 1998; 4: 2179-86.
15. Baramova EN, Bajou K, Remacle A et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 1997; 405: 157-62.
16. Mazzieri R, Masiero L. Zanetta L et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J 1997; 16: 101-4.
17. Negro A, Onisto M, Pellati D et al. CNTF up-regulation of TIMP-2 in neuroblastoma cells. Mol Brain Res 1997; 48: 30-6.
18. Sidell N, Altman A, Haussler MR et al. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 1983; 148: 21-30.
19. Chambaut-Guérin A-M, Hérigault S, Rouet-Benzineb P et al. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: Relevance to neuronal differentiation. J Neurochem 2000; 74: 508-17.
20. Sugiura Y, Shimada H, Seeger RC et al. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis. Cancer Res 1998; 58: 2209-16.
21. Barletta E, Mugnai G, Ruggieri S. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. Biol Chem 2002; 383: 189-97.
22. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1: 549-53.
23. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736.
24. Bravo J, Heath JK. Receptor recognition by gp130 cytokines. EMBO J 2000; 19: 2399-411.
25. Arcangeli A, Becchetti A. Mannini A et al. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 1993; 122: 1131-43.
26. Negro A, Tolosano E, Skaper SD et al. Cloning and expression of human ciliary neurotrophic factor. Eur J Biochem 1991; 201: 289-94.
27. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-9.
28. Unemori EN, Hibbs MS, Amento EP. (1991). Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 1991; 88: 1656-62.
29. Heinicke E, Kumar U, Munoz DG. Quantitative dot-blot assay for proteins using enhanced chemiluminescence. J Immunol Meth 1992; 152: 227-36.
30. Fibbi G, Barletta E, Dini G et al. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen receptor system in muscle satellite cells from normal and dystrophic patients. Lab Invest 2001; 81: 27-39.
31. Quattrone A, Papucci L, Santini V et al. Quantitation of bcl-2 oncogene in cultured lymphoma/leukemia cell lines and in primary leukemia B-cells by a highly sensitive RT-PCR method. Haematologica 1995; 80: 495-504.
32. Itoh T, Tanioka M, Matsuda H et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999; 17: 177-81.
33. Yamamoto M, Mohanam S. Sawaya R et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996; 56: 384-92.
34. Lardot C, Delos M. Lison D. Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles. Am J Physiol 1998; 274: L1040-8.
35. Kherif S, Lafuma C, Dehaupas M et al. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: A study in experimentally injured and mdx muscles. Dev Biol 1999; 205: 158-70.
36. Planchenault T, Costa S, Fages C et al. Differential expression of laminin and fibronectin and of their related metalloproteinases in human glioma cell lines: Relation to invasion. Neurosc Lett 2001; 299: 140-4.
37. Annabi B, Lachambre MP, Bousquet-Gagnon N et al. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim Biophys Acta 2002; 1542: 209-20.
38. De Chiara TM, Vejsada R, Poueymirou WT et al. (1995) Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995; 83: 313-22.
39. De Veas RG, Schweigerer L, Medina MA. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity. J Cancer Res Clin Oncol 1995; 121: 275-8.
40. Fowler C, Zimmer C, Boghaert E et al. Metastasis of C1300 and TBJ murine neuroblastomas correlates with expression of matrix metalloproteinases. Cancer Lett 1995; 93: 171-7.
41. Quaranta V. Cell migration through extracellular matrix: Membrane-type metalloproteinases make the way. J. Cell Biol 2000; 149: 1167-70.